BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
No Bill, Trade and International Negotiation, regarding intellectual property rights in trade agreements and international negotiations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RONALD MILLER | — |
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
| PAUL ANTHONY WILLIAMS | — |
Budget/Appropriations BUD
S.Con.Res.8 and H.Con. Res 25 concurrent resolutions setting forth the congressional budget for the United States Government for fiscal year 2014, revising the appropriate budgetary levels for fiscal year 2013, and setting forth the appropriate budgetary levels for fiscal years 2015 through 2023. Regarding Medicare and biopharmaceutical provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RONALD MILLER | — |
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
| PAUL ANTHONY WILLIAMS | — |
Health Issues HCR
H. J. Res 59, "Making continuing appropriations for fiscal year 2014, and for other purpose," regarding AIDS Drug Assistance Program, Medicare, and importation of prescription drugs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RONALD MILLER | — |
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
Medicare/Medicaid MMM
H.R. 2010, S. 1821, legislation reforming Medicare's Sustainable Growth Rate, regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RONALD MILLER | — |
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
Copyright/Patent/Trademark CPT
H.R. 3309, S. 1720, and S. 1612, S. 1013, S. 866, legislation to amend certain patent laws. Regarding all provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RONALD MILLER | — |
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
| PAUL ANTHONY WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.